Influence of socioeconomic status on antipsychotic prescriptions among youth in France

Recent studies analysing the trends in antipsychotic (AP) prescriptions for children and adolescents have raised concerns regarding the influence of socioeconomic status. Previous findings have also shown variable prescription rates for first-generation (FG) and second-generation (SG) APs. Our objec...

Full description

Saved in:
Bibliographic Details
Published in:BMC psychiatry 2017-02, Vol.17 (1), p.82-82, Article 82
Main Authors: Bonnot, Olivier, Dufresne, Mélanie, Herrera, Paula, Michaud, Emmanuelle, Pivette, Jacques, Chaslerie, Anicet, Sauvaget, Anne, Vigneau, Caroline
Format: Article
Language:English
Subjects:
Adolescent
Antipsychotic Agents - therapeutic use
Antipsychotics
Child
Child & adolescent psychiatry
Children & youth
Cohort analysis
Drug Prescriptions - statistics & numerical data
Female
France - epidemiology
Humans
Information systems
Life Sciences
Male
National health insurance
Psychiatry
Psychotic Disorders - drug therapy
Psychotic Disorders - psychology
Psychotropic drugs
Social Class
Teenagers
Trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies analysing the trends in antipsychotic (AP) prescriptions for children and adolescents have raised concerns regarding the influence of socioeconomic status. Previous findings have also shown variable prescription rates for first-generation (FG) and second-generation (SG) APs. Our objectives were to assess the proportion of patients from low-income families receiving APs and the most commonly prescribed APs in France. We conducted a descriptive analysis of AP drugs dispensed during a 1-year period (July 1, 2013-June 30, 2014) in a northwestern region of France with 941,857 subjects less than 18 years old. All data were extracted from an exhaustive, individual and anonymous social security database. We obtained each subject's socioeconomic status (by identifying their affiliation with a specific social security program) and also collected sociodemographic data, drug type, prescribing and dispensing dates and amount, and prescriber type (e.g., hospital physician, general practitioner, psychiatrist, paediatrician). There were two main novel findings. First, we found that the proportion of patients with AP prescriptions was nearly ten times higher in low-income families than in the general population: 35.9% of CMU-C patients compared to 3.7% in all of Pays de la Loire (X  = 7875.1, p 
ISSN:1471-244X
1471-244X
DOI:10.1186/s12888-017-1232-3